The feedback loop between miR-124 and TGF-β pathway plays a significant role in non-small cell lung cancer metastasis

Lidong Zu1,2, Yunjing Xue3, Jinglong Wang3

  • 1Pathology Center, Shanghai General Hospital/Faculty of Basic Medicine, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.

Carcinogenesis
|January 29, 2016
PubMed

Insights

MicroRNAs (miRNAs) are crucial in cancer. This study reveals miR-124 loss promotes non-small cell lung cancer (NSCLC) metastasis by regulating the TGF-β pathway, offering new therapeutic targets.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • MicroRNAs (miRNAs) are increasingly recognized for their roles in tumorigenesis.
  • The specific involvement of miRNAs in non-small cell lung cancer (NSCLC) metastasis is not well understood.

Purpose of the Study:

  • To investigate the role of miR-124 in NSCLC metastasis.
  • To elucidate the molecular mechanisms underlying miR-124's function in NSCLC progression.

Main Methods:

  • Analysis of miR-124 expression in NSCLC tissues.
  • In vitro and in vivo experiments to assess the effect of miR-124 restoration on cell migration, invasion, and metastasis.
  • Identification and validation of Smad4 as a direct target of miR-124.
  • Investigation of the feedback loop involving miR-124, Smad4, and the transforming growth factor-β (TGF-β) pathway.

Main Results:

  • miR-124 expression was significantly decreased in NSCLC tissues and correlated with metastasis.
  • Restoring miR-124 suppressed NSCLC cell migration, invasion, and metastasis.
  • Smad4 was identified as a direct target of miR-124, and its modulation affected cell migration and invasion.
  • A feedback loop involving miR-124, Smad4, and TGF-β signaling was identified, influencing epithelial-mesenchymal transition and NSCLC metastasis.

Conclusions:

  • The feedback loop between miR-124 and the TGF-β pathway is critical for NSCLC metastasis.
  • Targeting this regulatory loop presents a potential therapeutic strategy for preventing NSCLC metastasis.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.9K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.8K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.1K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
8.6K